Publications of Markus Zweckstetter
All genres
Journal Article (285)
41.
Journal Article
144 (6), pp. 2501 - 2510 (2022)
Molecular Basis of Small-Molecule Binding to α-Synuclein. Journal of the American Chemical Society 42.
Journal Article
119 (7), e2114215119 (2022)
The pathogenic R5L mutation disrupts formation of Tau complexes on the microtubule by altering local N-terminal structure. Proceedings of the National Academy of Sciences of the United States of America 43.
Journal Article
14, 15 (2022)
A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro. Alzheimer's Research & Therapy 44.
Journal Article
13, 3668 (2022)
Hsp multichaperone complex buffers pathologically modified Tau. Nature Communications 45.
Journal Article
159 (3), pp. 554 - 573 (2021)
Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils. Journal of Neurochemistry 46.
Journal Article
7, 65 (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 47.
Journal Article
12, 4231 (2021)
Co-factor-free aggregation of tau into seeding-competent RNA-sequestering amyloid fibrils. Nature Communications 48.
Journal Article
30 (7), pp. 1294 - 1314 (2021)
Liquid–liquid phase separation of tau: From molecular biophysics to physiology and disease. Protein Science 49.
Journal Article
15, 643391 (2021)
Low-Expressing synucleinopathy mouse models based on oligomer-forming mutations and C-terminal truncation of α-synuclein. Frontiers in Neuroscience 50.
Journal Article
12, 3396 (2021)
Proline/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis. Nature Communications 51.
Journal Article
13, 635760 (2021)
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity. Frontiers in Aging Neuroscience 52.
Journal Article
50 (2), pp. 107 - 108 (2021)
Special issue: Multicomponent lipid membranes—how molecular organisation leads to function. European Biophysics Journal 53.
Journal Article
78 (5), pp. 2355 - 2370 (2021)
Cooperativity of membrane-protein and protein–protein interactions control membrane remodeling by epsin 1 and affects clathrin-mediated endocytosis. Cellular and Molecular Life Sciences 54.
Journal Article
50 (2), pp. 159 - 172 (2021)
Structure, gating and interactions of the voltage-dependent anion channel. European Biophysics Journal 55.
Journal Article
50 (2), pp. 173 - 180 (2021)
Membrane-embedded TSPO: an NMR view. European Biophysics Journal 56.
Journal Article
A novel SNCA A30G mutation causes familial Parkinsonʼs disease. Movement Disorders, In Press (2021)
57.
Journal Article
125 (5), pp. 1378 - 1391 (2021)
Structural Flexibility of Cyclosporine A Is Mediated by Amide Cis–Trans Isomerization and the Chameleonic Roles of Calcium. Journal of Physical Chemistry B 58.
Journal Article
Interplay between tau and α‐synuclein liquid–liquid phase separation. Protein Science, In Press (2021)
59.
Journal Article
60 (2), pp. 726 - 730 (2021)
Disease‐associated tau phosphorylation hinders tubulin assembly within tau condensates. Angewandte Chemie International Edition 60.
Journal Article
10, 21210 (2020)
Solid-state NMR investigation of the involvement of the P2 region in tau amyloid fibrils. Scientific Reports